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Abstract 
Chromatographic separation of a crude extract obtained from the fungus Aspergillus 
sp., isolated from the Mediterranean sponge Tethya aurantium, yielded five new 
meroterpenoid metabolites, austalides M-Q (1-5), together with nine known 
compounds (6-13). The structures of the new compounds were unambiguously 
elucidated on the basis of extensive 1D and 2D NMR methods and mass spectral 
analysis. Furthermore, the absolute configurations of 1 and 4 were determined by 
TDDFT ECD calculations allowing the assignment of derivatives 2, 3 and 5 as well. 
The calculations revealed that the conformation of the benzene-fused phtalide 
chromophore, sensitive to even minor changes in its proximity, is decisive for the 
ECD parameters rendering the simple ECD comparison of related homochiral 
austalides difficult. All compounds were evaluated for their cytotoxic activity against 
murine cancer cell line L5178Y by the MTT method. Compounds 8 and 11 exhibited 
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moderate to pronounced cytotoxicity with IC50 values of 39.4 and 0.2 μM, 
respectively, whereas the remaining investigated compounds showed weak or no 
activity in this assay. 
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Introduction 
Over the past years, marine microorganisms have proven to be a prolific source of 
structurally interesting and biologically active natural products. Marine fungi in 
particular have attracted considerable interest due to the diversity in chemical 
structures and biological activities observed for their secondary metabolites.[1,2]  
Bioactive natural products from marine-derived fungi were reported for the first time 
back in the 1940s from a fungal strain of Acremonium chrysogenum, which yielded 
cephalosporin C, the parent compound of cephalosporin antibiotics.[3] Meanwhile, 
marine-derived fungi have been isolated from various organisms, including algae, 
mollusks and particularly sponges.[4,5] Yet, sponge-derived fungi were found to be 
among the most prolific sources of bioactive compounds.[6]  
The genus Aspergillus (Moniliaceae) contains approximately 180 species found in 
various climates worldwide in both terrestrial and marine environments.[7] Aspergillus 
species and their chemical profiles have been studied by numerous research groups. 
The genus has proven to be a rich source of secondary metabolites with novel 
structures and interesting bioactivity.[8-12] Examples of isolated metabolites include 
meroterpenoids,[11,13-15] isochroman derivatives,[10,16-18] drimane sesquiterpenoids,[8,19] 
and cyclic tripeptides,[12] which exhibited interesting biological activities, such as 
plant growth inhibition,[16] cytotoxic activity against tumor cell lines,[8,10] selective 
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antifungal activity,[12] as well as inhibition of endothelin-type B receptors.[19]  
As part of our ongoing research on marine fungi,[8,20,21] we have investigated a 
marine-derived fungal Aspergillus strain, isolated from a specimen of the 
Mediterranean sponge Tethya aurantium. In this study five new meroterpenoids, 
named austalides M-Q (1-5) (Figure 1), along with nine known compounds (6-13), 
were isolated. Previously known compounds were identified by comparing their 
spectroscopic and physical data (1H and 13C NMR, MS and [α]D) with literature 
values. The structure elucidation of the new metabolites, austalides M-Q (1-5), is 
described in detail. Moreover, all compounds isolated were evaluated for their 
cytotoxicity against the murine lymphoma cell line L5178Y using the MTT assay. 
 
Results and Discussion 
The mycelia and culture medium of the fungus Aspergillus sp. were extracted with 
ethyl acetate. The resulting crude ethyl acetate extract was subjected to repeated 
column chromatography followed by semi-preparative HPLC separation to obtain five 
new austalides M-Q (1-5) (Figure 1), along with eight known compounds (6-13). 
Based on the spectroscopic data and comparison with data reported in the literature, 
the known compounds 6-13 (Figure 2) were readily identified as 
4-acetyl-3,4-dihydro-6,8-dihydroxy-3-methoxy-5-methylisocoumarine (6),[22] 2,3,4- 
trimethyl-5,7-dihydroxy-2,3-dihydrobenzofuran (7),[23] 4-acetyl-3,4-dihydro-6,8- 
dihydroxy-5-methylisocoumarine (8),[24] phenol A acid (9),[25] butyrolactone II 
(10),[26,27] methyl-3,4,5-trimethoxy-2-(2-(nicotinamido)benzamido)benzoate (11),[28] 
citrinin (12),[29] and dicitrinin A (13).[30,31] Compound 11, previously isolated from 
Aspergillus fumigatus collected from the air and dust of asthmatic patients’ rooms,[32] 
is reported here for the first time from a sponge associated fungus. The new 
metabolites (1-5) were found to be structurally related to the known austalides A-L 
previously isolated from Aspergillus ustus.[13,14] 
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The molecular formula of 1 was established as C27H36O9 on the basis of the 
[M+H]+ signal at m/z 505.2423 in the HRESIMS. Its UV spectrum showed maxima at 
λmax 223 and 267 nm characteristic of a substituted phthalide moiety.[14] 1H and 13C 
NMR spectra (Tables 1 and 3) indicated the presence of eight methyl groups 
appearing as singlets in the 1H NMR spectrum, including three methoxy groups 
resonating at δH 3.40, 3.50 and 4.13 ppm (CH3-28, -31 and -29, respectively), one 
aromatic methyl group at δH 2.08 ppm (CH3-23), and four aliphatic methyl groups at 
δH 0.90, 1.33, 1.48 and 1.60 ppm (CH3-27, -24, -26 and -25, respectively). In addition, 
four methylene groups were observed, one of which was attributed to the oxygenated 
benzylic methylene group at C-1 (δH 5.23 ppm, s), as well as three methine groups, 
two of which are situated on oxygen-bearing carbon atoms as indicated by their 
chemical shift values at δH 4.11 and 4.44 ppm (H-13 and H-22, respectively). The 13C 
NMR spectrum (Table 3) confirmed the presence of 27 carbon atoms in the structure. 
Furthermore, the DEPT experiment revealed the presence of 12 quaternary carbon 
atoms. Analysis of the 1H-1H COSY spectrum of 1 (Table 1, Figure 3) established the 
presence of three spin systems which included the correlations observed for the 
methylene protons resonating at δH 2.19 and 2.32 ppm (CH2-12) to the deshielded 
methine group at C-13, and for the methine proton appearing at δH 2.50 ppm (H-21) to 
the deshielded methine group at C-22. Moreover, the correlation between the protons 
of both methylene groups at C-18 and C-19 verified the third spin system. 
Interpretation of the HMQC spectrum allowed the assignment of proton signals to the 
corresponding proton-bearing carbon atoms. 
The connection between the different substructures of 1 was determined by 
inspection of the HMBC spectrum (Table 1, Figure 3). The tertiary methyl group 
CH3-27 (δC 19.2) correlated with the quaternary carbon C-20 (δC 39.8), CH2-19 (δC 
31.4), CH-21 (δC 43.6), and an oxygenated quaternary carbon resonating at δC 87.7 
assigned to C-14. C-14 further correlated with the methyl groups CH3-25 and CH3-26 
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(δC 26.5 and 29.2, respectively), which were found to constitute a geminal dimethyl 
moiety, as indicated by their correlation with each other as well as with an oxygenated 
quaternary carbon resonating at δC 86.1 (C-15). Furthermore, the methoxy group 
OCH3-28 (δC 49.0) correlated with a highly deshielded quaternary carbon resonating 
at δC 120.3 which was assigned to C-17, in agreement with reported chemical shifts 
observed for the carbon atom of ortho esters.[14] H-21 correlated with C-20, C-22, 
CH3-27, and an aromatic quaternary carbon at δC 119.4 (C-6). The location of 
OCH3-31 (δC 56.4) was established based on its correlation with C-22. H-22 
correlated with C-20, C-31, C-6, as well as with three oxygenated quaternary carbons, 
two aromatic ones overlapping at δC 158.9, and an aliphatic one at δC 77.3, assigned 
to C-5, C-7 and C-11, respectively. Correlations of the tertiary methyl group CH3-24 
(δC 28.8) with C-11, C-21 and CH2-12 (δC 43.8) provided the remaining connections 
of the spin systems previously observed in the 1H-1H COSY spectrum. The methoxy 
group OCH3-29 (δC 63.3) was attached to C-5 as indicated by the respective HMBC 
correlation. The aromatic CH3-23 (δC 10.7) correlated to the quaternary aromatic 
carbons C-7, C-8 (δC 116.2), and C-9 (δC 149.3), and hence was placed at C-8. The 
remaining 13C resonances at δC 108.9 and 171.5 were attributed to the remaining sp2 
carbon atom of the completely substituted benzene ring (C-4) and the carbonyl carbon 
C-3, respectively. This was further confirmed by correlation of C-9 with the 
oxygenated benzylic methylene group CH2-1 (δC 70.0), which in turn correlated with 
C-4 and C-3. 
The relative configuration of 1 was deduced from analysis of the ROESY 
spectrum. Correlations were observed for CH3-24 to H-21 indicating that rings C and 
D are cis-fused. This was further confirmed by OCH3-31 correlations to H-21 and 
CH3-24. The correlation observed between CH3-27 and H-22, but not to H-21, 
indicated a trans relationship between CH3-24 and CH3-27. CH3-25 and CH3-27 as 
well as CH3-26 and H-13 are cis oriented based on the correlations observed between 
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them. Consequently, ring C is cis-fused with ring B and trans-fused with the 
seven-membered ring. Thus, the relative stereochemistry of 1 was established as 
(11S*,13R*,14R*,20R*,21S*,22S*). For the determination of the absolute 
configuration, the solution ECD spectrum of 1 was recorded in acetonitrile and 
TDDFT ECD calculation of solution conformers was carried out. The experimental 
ECD spectrum is dominated by the strong negative Cotton effect (CE) at 217 nm (Δε= 
16.00) accompanied by a positive CE at 196 nm (Δε= 5.61) and three weaker 
transitions at 262, 295 and 301 nm (Figure 4). The MMFF conformational search 
followed by B3LYP/6-31G(d) DFT reoptimization afforded two conformational 
isomers (conformer A and B in Figure 5 with 77.2% and 19.5% populations) above 
3% population. The two conformers showed minor differences in the orientations of 
methoxy and hydroxy groups and the conformation of the fused phtalide moiety. In 
both conformers, the benzylic 22-OMe group adopted axial orientation to relieve the 
peri interaction with the 5-OMe group and the pyran ring of the chroman 
chromophore had M helicity. The weak coupling between H-22 and the contiguous 
H-21, indicating a torsion angle close to 90° between these vicinal protons,[33] 
corroborated the axial orientation of the 22-OMe group. In spite of their similarities, 
the computed ECD spectra of the two conformers were significantly different (Figure 
SI1 and SI2), i.e. the major conformer reproduced well the two intense high-energy 
CEs, while the minor one seems responsible for the negative CE at 262 nm. The 
different ECDs of the conformers were attributed to the different orientation of the 
C-3 carbonyl relatively to the benzene ring (ωO3,C3,C4,C9). The torsional angle 
ωO3,C3,C4,C9 was found to be –178.8° for the major conformer and +174.3° for the 
minor one. The Boltzmann-weighted ECD spectra of the two conformers reproduced 
well the two strong CEs of the high-energy region, which allowed determining the 
absolute configuration of 1 as (–)-(11S,13R,14R,20R,21S,22S). However, the 
agreement was quite poor for the weak transitions above 250 nm, which could be 
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improved by setting the ratio of the two conformers to 1:1 (see Figure SI3). The CD 
calculation revealed that the ωO3,C3,C4,C9 torsional angle and ratio of the conformers, 
determined by the central chirality elements, are decisive for the observed CEs, which 
makes the application of the chroman helicity rule[34] unrelevant.  
The absolute configuration of 1 corraborates those determined for austalides A and 
D by X-ray crystallographic studies.[15,35] However, austalide D has an additional 
chirality center due to an additional C-19 acetoxy group, and the C-22 chirality center 
of 1 is missing from both austalides A and D due to the lack of the 22-methoxy 
substituent.[15,35] Thus, 1 was identified as a new natural product and named as 
austalide M. 
Compound 2 displayed similar spectral data to those of 1 suggesting that both 
compounds have the same basic molecular framework. HRESIMS indicated the 
molecular formula C28H36O10 in accordance with the [M+H]+ signal at m/z 533.2388, 
thus revealing a 28 amu increase in the molecular weight compared to 1. 1H, 13C 
NMR and DEPT spectra of 2 were similar to those of 1 (Tables 1 and 3) except for the 
replacement of the benzylic C-22 methoxy group by a methyl ester group resonating 
at δH 2.07 and δC 21.3 (CH3-32). The respective ester carbonyl carbon was detected at 
δC 171.6 (C-31). This was further confirmed by the observed downfield chemical shift 
of the H-22 signal (δH 6.21) caused by the acetyl substituent. Inspection of COSY, 
HMQC and HMBC spectra (Table 1) indicated that apart from the methyl ester 
function at C-22, the two compounds were identical. Based on the ROESY spectrum, 
2 has (11S*,13R*,14R*,20R*,21S*,22S*) relative configuration in accordance with 
the corresponding chirality centers of 1. Accordingly, 2 was finally characterized as a 
new natural product named austalide N.  
The molecular formula of 3 was determined as C26H34O9, from the prominent 
signal at m/z 491.2293 corresponding to [M+H]+ in the HRESIMS, indicating a loss 
of 14 amu compared to 1. Physicochemical data of 3 were almost identical with those 
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of 1 (Tables 1 and 3) apart from the disappearance of the C-22 methoxy group in the 
NMR spectra of 3. This suggested that 3 possesses the same skeleton as 1 but it has a 
benzylic 22-OH group instead of the 22-OMe, which accounts for the 14 amu 
molecular weight difference. Accordingly, slight downfield and large upfield shifts 
were observed for H-22 (δH 4.97) and C-22 (δC 62.0), respectively, in the 1H and 13C 
NMR spectra of 3. As with 2, further confirmation of the planar structure was 
achieved by analysis of DEPT, COSY, HMQC and HMBC spectra (Table 1). 
Moreover, the ROESY spectrum indicated the (11S*,13R*,14R*,20R*,21S*,22S*) 
relative configuration in agreement with those of 1 and 2. Hence, 3 was identified as a 
new natural product and named austalide O. 
Compound 4 has the molecular formula of C26H36O7, from the HRESIMS with a 
prominent peak at m/z 483.2349 [M+Na]+. Its physical characteristics were also 
comparable to those of 1 suggesting the same basic molecular framework. 1H and 13C 
NMR spectra of 4 (Tables 2 and 3) indicate the presence of seven methyl groups 
appearing as singlets in the 1H NMR spectrum, including two methoxy groups 
resonating at δH 3.68 and 4.04 ppm (CH3-28 and -29, respectively), one aromatic 
methyl group at δH 2.08 ppm (CH3-23), and four aliphatic methyl groups at δH 0.70, 
1.20, 1.19 and 1.27 ppm (CH3-27, -24, -25 and -26, respectively). In addition, six 
methylene groups were observed, one of which was attributed to the oxygenated 
benzylic methylene group at C-1 (δH 5.21 ppm, s), as well as two methine groups. The 
13C NMR spectrum (Table 3) confirmed the presence of 26 carbon atoms in the 
structure. Furthermore, the DEPT experiment revealed the presence of 11 quaternary 
carbon atoms. Analysis of the 1H-1H COSY spectrum of 4 (Table 2, Figure 6) 
established the presence of three spin systems which included the fragment 
CH2(12)CH2(13)CH(14) based on the correlations observed between the 
corresponding protons resonating at δH 1.61 (CH2-12), 1.52 and 1.83 (CH2-13), as 
well as 2.14 (H-14) ppm, thus indicating the loss of the hydroxyl group substituent at 
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C-13 present in 1-3 as well as of the oxo-bridge connecting C-14 to C-17. Moreover, 
the correlation between the protons of methylene groups at C-18 (δH 2.32 and 2.60 
ppm) and C-19 (δH 1.80 and 2.42 ppm), and between the methylene protons appearing 
at δH 2.78 and 3.03 ppm (CH2-22) to the methine group at C-21 (δH 1.70 ppm) 
verified the remaining two spin systems. Proton signals were assigned to their 
corresponding carbon atoms by analysis of the HMQC spectrum. 
The structural units identified in 4 were connected on the basis of correlations 
observed in the HMBC spectrum (Table 2, Figure 6). The tertiary methyl group 
CH3-27 (δC 19.5) correlated with the quaternary carbon C-20 (δC 41.6), CH2-19 (δC 
34.9), CH-21 (δC 41.2), and CH-14 (δC 40.1). C-14 further correlated with the methyl 
groups CH3-25 and CH3-26 (δC 28.0 and 33.2, respectively), which were found to 
constitute a geminal dimethyl moiety, as indicated by their correlation with each other 
as well as with an oxygenated quaternary carbon resonating at δC 75.7 (C-15). The 
upfield chemical shift of C-15 in 4 compared to that observed in 1-3 indicated its 
location within a side chain and not as part of a seven-membered ring as in 1-3. 
Furthermore, the methoxy group OCH3-28 (δC 52.0) correlated with an ester carbonyl 
carbon resonating at δC 177.7 which was assigned to C-17. H-21 correlated with 
CH2-19, C-20, CH3-27, CH2-22 (δC 18.5), and C-6 (δC 118.0). CH2-22 correlated with 
C-20, CH-21, C-6, as well as with the oxygenated quaternary carbons C-5 (δC 158.1), 
C-7 (δC 160.0) and C-11 (δC 78.3). Correlations of the tertiary methyl group CH3-24 
(δC 27.9) with C-11, C-21 and CH2-12 (δC 40.2) provided the remaining connections 
of the spin systems previously observed in the 1H-1H COSY spectrum. The methoxy 
group OCH3-29 (δC 62.1) was attached to C-5 as indicated by the respective HMBC 
correlation. The aromatic CH3-23 (δC 10.6) correlated to the quaternary aromatic 
carbons C-7, C-8 (δC 117.3), and C-9 (δC 148.0), and hence was placed at C-8. The 
remaining 13C resonances at δC 108.0 and 172.1 were attributed to C-4 and C-3, 
respectively. This was further confirmed by correlation of C-9 with CH2-1 (δC 69.8), 
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which in turn correlated with C-8, C-4 and C-3. Accordingly, 4 shows familiar 
features to 1-3 except for that the seven-membered ring of 1-3 was opened at the 
oxo-bridges giving rise to 2 side chains located at C-20 and C-14 instead. 
The relative configuration of 4 was established by interpretation of the ROESY 
spectrum. By analogy with 1, CH3-24 correlated with H-21 thus denoting cis-fusion of 
rings C and D. This was further confirmed by correlations observed for H-21 with 
H-14 and CH3-24, indicating the cis orientation of H-21 and H-14. A trans 
relationship between CH3-24 and -27 was assumed from the absence of correlations 
between CH3-27 and H-14, H-21 or CH3-24. Accordingly, the relative stereochemistry 
of 4 was determined as (11S*,14R*,20S*,21R*). Compound 4 lacked the benzylic 
chirality center and its ECD spectrum was completely different from that of 1, which 
implied that ECD calculation was required for the configurational assignment. The 
ECD spectrum of 4 showed four main ECD bands at 267, 228, 212 and 194 nm with 
alternating negative, positive, negative, positive CEs, respectively (Figure 7). The 
MMFF conformational search followed by B3LYP/6-31G(d) DFT reoptimization of 
31 conformers afforded four conformational isomers with 40.0%, 23.5%, 16.8% and 
15.1% populations above 2% populations. Besides slightly different orientations of 
the side-chains, the value of the torsional angle ωO3,C3,C4,C9 was identified as the main 
difference among the conformers (Figure 8). In contrast to the situation for austalide 
M (1), the two lowest-energy conformers had positive torsional angle ωO3,C3,C4,C9, 
while the two higher-energy ones had negative ones. In accordance conformer A and 
B gave nearly identical calculated ECDs and different from those of conformer C and 
D, which were similar. The Boltzmann-weighted ECD spectra of (11S,14R,20S,21R)-4 
computed with TZVP basis set and three different functionals (B3LYP, BH&HLYP, 
PBE0) reproduced well the experimental ECD spectrum with PBE0 giving the best 
agreement (Figure 8). Thus the absolute configuration of 4 was unambiguously 
determined as (–)-(11S,14R,20S,21R) and it was named as austalide P. The ECD 
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calculation also revealed that the sign of the torsional angle ωO3,C3,C4,C9, i.e. the 
conformation of the benzene-fused pthalide ring, is decisive for the ECD parameters. 
The major conformers of austalide M (1) and P (4) had oppositely signed torsional 
angles ωO3,C3,C4,C9, which resulted in markedly different ECD spectra. The torsional 
angle ωO3,C3,C4,C9 of the conformers and their populations are clearly determined by 
the central chirality elements and the benzylic C-22 chirality center has obviously a 
determining role. The results of the ECD calculation also explain the fact that the 
ECD spectra (Figure 9) of austalide N (2) and O (3) were different from that of 
austalide M (1), although they are homochiral and they differ only in the nature of the 
benzylic C-22 substituent. The nature of the benzylic C-22 substituent (methoxy, 
acetoxy or hydroxyl) has an effect on the torsional angle ωO3,C3,C4,C9 of the conformers 
and their populations, which in turn determines the ECD parameters. The examples of 
austalides suggest that a simple comparison of their ECD spectra, a general procedure 
for the determination of absolute configuration for structurally related compounds, 
can not be used safely in the presence of a chirally perturbed benzene-fused phtalide 
chromophore. 
The HRESIMS of 5 exhibited a prominent peak at m/z 459.2376 [M+H]+ 
indicating a molecular formula of C26H34O7. The 1H, 13C NMR and DEPT data of 5 
(Tables 2 and 3) were similar to those of 4 apart from the replacement of one of the 
methylene protons at C-13 by a hydroxyl group in 5, as evidenced by the chemical 
shifts of CH-13 (δH 4.11, δC 72.2). In addition, the hydroxyl group at C-15 of 4 was 
absent and one of the geminal methyl groups was replaced by an olefinic methylene 
group, the protons of which resonate downfield at δH 4.96 and 5.05 ppm (CH2-25). 
This was further confirmed by the analysis of the 1H-1H COSY spectrum (Table 2) 
which verified the fragment CH2(12)CH(13)CH(14) derived from the correlations 
observed between the methylene protons at δH 2.02 and 2.41 ppm (CH2-12), the 
proton at C-13, and H-14 detected at 2.20 ppm. HMQC and HMBC spectra (Table 2) 
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gave further evidence for the assigned partial structures of 5. The correlations 
observed for CH3-26 (δH 1.90) to C-14 (δC 54.3), the olefinic quaternary carbon 
detected at δC 148.0 (C-15), and an olefinic methylene carbon at δC 116.2 ppm (C-25), 
confirmed the dehydrogenation of the C-15—C-25 bond in 5 compared to that of 4. 
The ROESY spectrum of 5 showed similar correlations to those of 4 indicating 
(11S*,13R*,14S*,20S*,21R*) relative configuration, which regarding the 
corresponding chirality centers, was homochiral with that of austalide M (1). Since 
compound 5 exhibited nearly identical ECD spectrum with that of 4 and the C-11 and 
C-21 chirality centers, the closest ones to the substituted chroman chromophore, were 
the same, its absolute configuration was determined as (–)-(11S,13R,14S,20S,21R) 
and it was named austalide Q. 
The main structural difference between the new austalides M-Q (1-5) and 
previously reported austalides with the same molecular framework is the presence of 
an additional substituent at C-22 in 1-3, compared to the known austalides A-F.[13,14] 
Furthermore, austalide P (4) lacks a substituent at C-13 having a methylene group in 
this position, whereas austalide Q (5) features a C-15—C25 double bond, compared to 
the structurally related austalides G and H.[13,14]  
Compounds 1-13 were evaluated for their cytotoxic activity against the murine 
cancer cell line L5178Y by the MTT assay.[36] Only compound 8 exhibited 
pronounced cytotoxicity with an IC50 values of 0.2 µM. Compound 11 showed 
moderate activity (IC50 39.4 µM), whereas the remaining compounds showed weak or 
no activity in the assay (Table 4). 
 
Experimental Section 
General Experimental Procedures: Optical rotations were determined on a 
Perkin-Elmer-241 MC polarimeter and CD spectra were recorded on a J-810 CD 
spectropolarimeter. 1H, 13C, and two-dimensional NMR spectra were recorded in 
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methanol-d4 on Bruker ARX 400 or Bruker ARX 500 NMR spectrometers. ESIMS 
was conducted on a Finnigan LCQ Deca mass spectrometer, and HRESIMS spectra 
were obtained on a FTHRMS-Orbitrap (Thermo-Finnigan) mass spectrometer. 
Solvents were distilled prior to use, and spectral grade solvents were used for 
spectroscopic measurements. HPLC analysis was performed using a Dionex P580 
system coupled to a photodiode array detector (UVD340S). Routine detection was at 
235, 254, 280, and 340 nm. The separation column (125 × 4 mm, L×i.d.) was prefilled 
with Eurospher-10 C18 (Knauer, Germany), and the following gradient was used 
(MeOH, 0.02% H3PO4 in H2O): 0 min, 10% MeOH; 5 min, 10% MeOH; 35 min, 
100% MeOH; 45 min, 100% MeOH. TLC plates with silica gel F254 (Merck, 
Darmstadt, Germany) were used for monitoring of fractions using 
dichloromethane/methanol-based solvent systems. Detection was at 254 and 366 nm 
or by spraying the plates with anisaldehyde reagent. 
 
Fungal material: The sponge Tethya aurantium, collected from the 
Mediterranean Sea near Italy, was surface sterilized by immersing in 70% ethanol for 
30 sec followed by rinsing three times in sterilized artificial sea water. Then, the 
sponge was cleaved aseptically into small segments (≈ 1.5 x 1.5 mm). The material 
was placed on a potato carrot agar medium and incubated at room temperature 
(25 °C). After several days hyphae growing from the sponge material were transferred 
to fresh plates with the same medium, incubated again and periodically checked for 
culture purity. The fungus was identified as Aspergillus sp. (Moniliaceae) using a 
molecular biological protocol[37] as well as by morphological characterization. 
 
Cultivation: Mass growth of the fungus for the isolation and identification of 
secondary metabolites was carried out on two different media, namely biomalt agar 
and spelt barley (composed of 200 g barley, 200 g spelt, 2 g soy protein, 2 mg MnCl2 
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und 250 mL distilled water) solid media for 21 days at 22 °C. The cultures obtained 
from both media were then lyophilized, extracted with ethyl acetate, and the dry 
residues left after evaporation were defatted with petroleum ether. 
 
Extraction and Isolation: The culture media were extracted with ethyl acetate to 
afford 35 g of dry residue after removal of solvent under reduced pressure. The 
EtOAc extract was then partitioned between n-hexane and 90% MeOH, the latter 
yielding 18.0 g dry residue. This residue was subjected to vacuum liquid 
chromatography (VLC) on silica gel employing a step gradient of 
dichloromethane/methanol to yield ten fractions (F1-F10). Fraction F2 (1.7 g) was 
subjected to chromatographic separation using HP-20 with a step gradient of 
water/methanol to yield 10. Sub-fractions were chromatographed on Sephadex LH-20 
with methanol as eluting solvent. Based on detection by TLC, fractions were 
combined and subjected to semi-preparative HPLC (Merck, Hitachi L-7100) using a 
Eurosphere 100-10 C18 column (300 × 8 mm, L×i.d.) with an eluting gradient of 
MeOH/H2O. Yields of compounds were as follows: 1 8.5 mg, 2 8.0 mg, 3 4.5 mg, 4 
4.5 mg, 5 1.6 mg, 6 11.0 mg, 7 28.0 mg, 8 7.5 mg, 9 6.0 mg, 10 120.0 mg, 12 1.9 mg, 
and 13 4.5 mg. Similarly, fraction F6 (771.6 mg) was chromatographed on Sephadex 
LH-20 with methanol as eluting solvent followed by semi-preparative HPLC to yield 
11 4.5 mg. 
Austalide M (1): brown amorphous solid (MeOH); [α]20D –43 (c 0.35, MeOH); 
UV (MeOH/H2O) λmax 223.7, 267.8 nm; ECD (MeCN), λ [nm] (Δε), c = 2.1 × 10−4): 
301 (–0.23), 295 (0.14), 262 (–2.07), 217 (–16.00), 196 (5.61). 1H and 13C NMR data, 
see Tables 1 and 3; ESIMS positive m/z 504.9 [M + H]+, 527.1 [M + Na]+; HRESIMS 
m/z 505.2423 [M + H]+ (calc. for C27H37O9, 505.2438). 
Austalide N (2): brown amorphous solid (MeOH); [α]20D –15 (c 0.40, MeOH); 
UV (MeOH/H2O) λmax 223.9, 266.9 nm; ECD (MeCN), λ [nm] (Δε), c = 3.1 × 10−4): 
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300sh (0.15), 284sh (–0.25), 264 (–0.92), 231 (–2.29), 224sh (–2.00), 201 (0.11). 1H 
and 13C NMR data, see Tables 1 and 3; ESIMS positive m/z 532.8 [M + H]+, 554.9 [M 
+ Na]+; HRESIMS m/z 533.2388 [M + H]+ (calc. for C28H37O10, 533.2387).  
Austalide O (3): brown amorphous solid (MeOH); [α]20D –41 (c 0.15, MeOH); 
UV (MeOH/H2O) λmax 222.8, 268.4 nm; ECD (MeCN), λ [nm] (Δε), c = 3.4 × 10−4): 
296 (0.35), 260sh (–1.25), 245 (–1.60), 225sh (1.77), 212 (5.02). 1H and 13C NMR 
data, see Tables 1 and 3; ESIMS positive m/z 490.8 [M + H]+, 513.1 [M + Na]+; 
HRESIMS m/z 491.2293 [M + H]+ (calc. for C26H35O9, 491.2281). 
Austalide P (4): brown amorphous solid (MeOH); [α]20D –35 (c 0.15, MeOH);  
UV (MeOH/H2O) λmax 221.7, 270.1 nm; ECD (MeCN), λ [nm] (Δε), c = 3.6 × 10−4): 
295sh (–0.92), 267 (–4.41), 239sh (–1.10), 228 (4.01), 212 (–4.43), 194 (2.28). 1H and 
13C NMR data, see Tables 2 and 3; ESIMS positive m/z 460.8 [M + H]+, 483.1 [M + 
Na]+, 943.0 [2M + Na]+; HRESIMS m/z 461.2532 [M + H]+, 483.2349 [M + Na]+ 
(calc. for C26H37O7, 461.2539). 
Austalide Q (5): brown amorphous solid (MeOH); [α]20D –40 (c 0.16, MeOH); 
UV (MeOH/H2O) λmax 220.5, 267.7 nm; ECD (MeCN), λ [nm] (Δε), c = 2.6 × 10−4): 
294sh (–0.31), 263 (–2.01), 239sh (–0.37), 226 (2.78), 208 (–1.58), 194 (1.57). 1H and 
13C NMR data, see Tables 2 and 3; ESIMS positive m/z 459.0 [M + H]+, 481.1 [M + 
Na]+, 939.1 [2M + Na]+; HRESIMS m/z 459.2376 [M + H]+, 481.2195 [M + Na]+ 
(calc. for C26H35O7, 459.2383). 
 
Cell Proliferation Assay: Cytotoxicity was tested against L5178Y mouse 
lymphoma cells using a microculture tetrazolium (MTT) assay and compared to that 
of untreated controls as described previously.[38,39] Experiments were repeated three 
times and carried out in triplicate. As negative controls, media with 0.1% 
EGMME/DMSO were included in the experiments. The depsipeptide kahalalide F 
isolated from Elysia grandifolia[38] was used as positive control. 
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Computational section: Conformational searches were carried out by means of 
the Macromodel 9.7.211[40] software using Merck Molecular Force Field (MMFF) 
with implicit solvent model for chloroform. Geometry reoptimizations at 
B3LYP/6-31G(d) level of theory followed by TDDFT calculations using various 
functionals (B3LYP, BH&HLYP, PBE0) and TZVP basis set were performed by the 
Gaussian 03[41] package. Boltzmann distributions were estimated from the ZPVE 
corrected B3LYP/6-31G(d) energies. CD spectra were generated as the sum of 
Gaussians[42] with 3000 cm–1 half-height width (corresponding to ca. 16 nm at 230 
nm), using dipole-velocity computed rotational strengths for conformers above 3%. 
The MOLEKEL[43] software package was used for visualization of the results. 
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Table 3. 13C NMR data (methanol-d4) of 1-5, δ in ppm 
 
Position 1a 2a 3a 4b 5b 
1 70.0 69.9 69.9  69.8  70.7 
3 171.5 171.2 172.0 172.1 172.1 
4 108.9 108.5 108.8 108.0 108.0 
5 158.9 158.4 158.5 158.1 154.7 
6 119.4 116.0 116.0 118.0 118.0 
7 158.9 159.6 159.2 160.0 160.0 
8 116.2 116.4 116.1 117.3 117.3 
9 149.3 150.1 149.2 148.0 146.2 
11 77.3 77.1  77.1 78.3 79.3 
12  43.8  43.7  43.8  40.2
 
 46.6 
13 69.9 69.6  70.0  22.4  72.2 
14 87.7  87.6  87.6  40.1  54.3 
15  86.1  85.1  86.2  75.7 148.0 
17 120.3 120.6 120.5 177.7 176.7 
18 32.0  32.0  31.8 30.0 29.9 
19  31.4  31.6  31.8  34.9  36.0 
20  39.8  40.9  40.1  41.6  40.1 
21  43.6  46.3  48.0  41.2  40.7 
22  72.2 65.3  62.0  18.5  18.9 
23  10.7  10.6  10.8  10.6  10.8 
24  28.8  28.8  29.2  27.9  27.8 
25  26.5  26.4  26.4  28.0 116.2 
26  29.2  29.2  29.0  33.2  26.4 
27  19.2  19.2  19.0  19.5  20.7 
28  49.0  50.1  50.0  52.0  52.4 
29  63.3  63.1  62.2  62.1  62.7 
31  56.4 171.6    
32   21.3    
 
a 13C NMR (100 MHz)    b 13C NMR (150 MHz)   
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Table 4. Results of cytotoxicity assay for the isolated compounds 
 
Compound tested L5178Y growth   
inhibition in % 
(at 10 µg/mL) 
 
IC50 
(µg/mL) 
 
IC50 
(µM) 
Austalide M                                                 (1) 0   
Austalide N                                                 (2) 0   
Austalide O                                                 (3) 28.0   
Austalide P                                                 (4) 16.2   
Austalide Q                                                 (5) 41.7   
4-acetyl-3,4-dihydro-6,8-dihydroxy-3-methoxy-5-methylisocoumarin   (6) 9.3   
2,3,4-trimethyl-5,7-dihydroxy-2,3-dihydrobenzofuran               (7) 9.1   
4-acetyl-3,4-dihydro-6,8-dihydroxy-5-methylisocoumarin            (8) 76.9 9.3 39.4 
Phenol A acid                                               (9) 0   
Butyrolactone II                                             (10) 49.1   
Methyl 3,4,5-trimethoxy-2-(2-nicotinamidobenzamido)benzoate       (11) 100.1 0.1 0.2 
Citrinin                                                    (12) 35.8   
Dicitrinin A                                                 (13) 44.6   
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Figure 1. Structures of austalide M-Q (1-5) isolated from Aspergillus sp. 
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Figure 2. Known compounds (6-13) isolated from Aspergillus sp. 
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Figure 3. HMBC and 1H-1H COSY correlations of 1 
 
 
 
 
Figure 4. Experimental ECD spectrum of 1 in acetonitrile compared with the 
Boltzmann-weighted PBE0/TZVP spectrum calculated for the two lowest-energy 
conformers of the (11S,13R,14R,20R,21S,22S)-enantiomer 
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Figure 5. DFT optimized geometries of the two lowest-energy conformers of 
(11S,13R,14R,20R,21S,22S)-1 with torsional angle ωO3,C3,C4,C9  –178.8° and +174.3°, 
respectively 
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Figure 6. HMBC and 1H-1H COSY correlations of 4 
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Figure 7. Experimental ECD spectrum of 4 in acetonitrile compared with the 
Boltzmann-weighted PBE0/TZVP spectrum calculated for the four lowest-energy 
conformers with (11S,14R,20S,21R) absolute configuration. Bars represent rotational 
strengths (R) of the lowest-energy conformer (40.0%) 
 
 
Figure 8. DFT optimized geometries and populations of the four lowest-energy 
conformers of (11S,14R,20S,21R)-4 with torsional angle ωO3,C3,C4,C9 +174.61°, 
+174.92°, –176.28° and –175.94°, respectively 
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Figure 9. Experimental ECD spectra of austalide M (1, red), austalide N (2, green), 
austalide O (3, blue), austalide P (4, black) and austalide Q (5, cyan) in acetonitrile 
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Supporting Information 
 
Figure SI1. Experimental ECD spectrum of 1 compared with the PBE0/TZVP 
spectrum of the lowest-energy (11S,13R,14R,20R,21S,22S)-conformer (conformer A, 
77.2% population). Bars represent rotational strengths (R) 
 
Figure SI2. Experimental ECD spectrum of 1 compared with the PBE0/TZVP 
spectrum of (11S,13R,14R,20R,21S,22S)-conformer B (19.5% population). Bars 
 27 
represent rotational strengths (R) 
 
Figure SI3. Experimental ECD spectrum of 1 compared with the PBE0/TZVP 
spectrum of the two lowest-energy (11S,13R,14R,20R,21S,22S)-conformers supposing 
their 1:1 ratio 
